Prognosis
White House Works With Seven Drugmakers in ‘Warp Speed’ Push
Photographer: Adam Glanzman/Bloomberg
This article is for subscribers only.
The White House is working with seven pharmaceutical companies as part of its “Warp Speed” coronavirus vaccine program, including a bet on a rapid-but-unproven genetic technology.
The companies include Johnson & Johnson, Merck & Co., Pfizer Inc., the Cambridge, Massachusetts-based biotech Moderna Inc., and the University of Oxford in collaboration with AstraZeneca Plc, as well as two other firms, according to two people familiar with the matter. President Donald Trump was briefed Tuesday on the latest details on the project, according to one of the people.